Page 286 of 287: studies 2,851 to 2,860 of 2,864, newest first. Back to the cannabis overview
Minnesota law review 1970 Stephen D. Ford 1 citation
1. DeShon, Rinkel & Solomon, Mental Changes Experimentally Produced by LSD, 26 PSYCHIAT.Q. 33 (1952).2. Stoll & Hofmann, Partialsynthese von AlkalZiden vom Typus des Ergobasins, 26 HELvET.CHim.AcmA.944 (1943).See Laughlin, LSD-25 and the Other Hallucinogens: A Pe-Reform Proposal, 36 GEo.WAsH.L. REv. 23, 27 n.23 (1967), for a brief discussion of the history and sources of the other...
JAMA September 9, 1968 Lionel Grossbard 23 citations
Acute leukemia occurred in a user of several hallucinogenic drugs (lysergic acid diethylamide [LSD], mescaline, marihuana, and amphetamines). The leukemic leukocytes of the patient contained a Ph1-like chromosome; lymphocytes transformed with phytohemagglutinin did not show chromosome breaks. A Ph1-like chromosome has only rarely been reported in either acute leukemia or in cultured lymphocytes...
JAMA September 14, 1963 Dana L. Farnsworth 11 citations
An article on stramonium intoxication in this issue ofThe Journal(p 882) calls attention to a growing medical and social problem in this country—the ingestion of a number of drugs which have the common property of drastically altering sensory perception. The drugs all produce hallucinations. In addition to stramonium, the drugs include mescaline or peyote, lysergic acid diethylamide (LSD-25),...
Journal of Addiction Medicine Kevin H. Yang, Wayne Kepner, Anamika Nijum et al. 11 citations
3,4-Methylenedioxymethamphetamine (MDMA) (also known as "ecstasy" or "Molly") has regained attention in recent years for its efficacy in treating posttraumatic stress disorder, and the drug was granted breakthrough therapy designation for such use by the US Food and Drug Administration in 2017. However, little is known about the current epidemiology of recreational ecstasy/MDMA use. We...
Journal of Clinical Psychopharmacology Giordano Novak Rossi, Juliana Mendes Rocha, Flávia L. Osório et al. 12 citations
Serotonergic hallucinogens and cannabinoids may alter the recognition of emotions in facial expressions (REFE). Cannabidiol (CBD) attenuates the psychoactive effects of the cannabinoid-1 agonist tetrahydrocannabinol. Ayahuasca is a dimethyltryptamine-containing hallucinogenic decoction. It is unknown if CBD may moderate and attenuate the effects of ayahuasca on REFE. Seventeen healthy...
Manoj K. Doss, Harriet de Wit, David A Gallo preprint
Psychoactive drugs modulate learning and emotional processes in ways that could impact their recreational and medical use. Recent work has revealed how drugs impact different stages of processing emotional episodic memories, including encoding (formation of memory traces), consolidation (stabilization of memory traces), and retrieval (accessing memory traces). Drugs administered before encoding...
Carolyn M. L. Crawford, Zach Walsh, W. Francois Louw et al.
Chronic pain is a prevalent and disabling condition, making access to safe and effective pain treatments a public health priority. Early but encouraging results have emerged from research investigating the therapeutic potential of psilocybin for people living with chronic pain (PLCP). This growing line of work urges an understanding of PLCP’s receptivity to this treatment. Aim. The primary aim...
Valeria Serra, Federico Brandalise, Vivien Miczán et al.
Abstract Dynamic regulation of midbrain dopamine neuron activity is necessary for diverse processes including motivation, novelty detection, reinforcement learning, and cognitive flexibility. By setting the strength of synaptic inputs to dopaminergic neurons, endocannabinoid signaling is essential for regulating dopaminergic activity. Prenatal exposure to Δ9-tetrahydrocannabinol (THC), the main...
Hüseyin Beyköylü, Josi Marschall, Elio Sjak-Shie et al. preprint
Virtual reality psychedelic experiences (VRPEs) may offer accessible alternatives to substance-induced psychedelic experiences, but their phenomenology and how set and setting factors shape the experience remain underexplored. We conducted a study in a naturalistic festival setting where participants (N = 210) engaged with a 7-minute VRPE while continuous intensity ratings and physiological...
Théo Mouhoud, Timothée Lacombe, Olivier Taieb preprint
Abstract Background Nutmeg ( Myristica fragrans ) active compounds partially metabolize into amphetamine derivatives with hallucinogenic properties. Acute nutmeg intoxication can induce psychotic states, yet this psychotomimetic potential remains largely unrecognized in clinical practice. We report the first case of nutmeg-induced acute psychosis in an adolescent, highlighting the diagnostic...